Complete remission of multiple myeloma associated scleredema after bortezomib-based treatment.
Petr
P
Szturz
Zdeněk
Z
Adam
Vladimír
V
Vašků
Josef
J
Feit
Marta
M
Krejčí
Luděk
L
Pour
Roman
R
Hájek
Jiří
J
Mayer
D000970:Antineoplastic Agents / Q000627:therapeutic use; D001897:Boronic Acids / Q000627:therapeutic use; D000069286:Bortezomib; D006801:Humans; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000150:complications* / Q000188:drug therapy; D010641:Phenotype; D011719:Pyrazines / Q000627:therapeutic use; D012074:Remission Induction; D012592:Scleredema Adultorum / Q000175:diagnosis / Q000209:etiology*
D000970:Antineoplastic Agents; D001897:Boronic Acids; D011719:Pyrazines; D000069286:Bortezomib